119 related articles for article (PubMed ID: 8713696)
41. Concentrations of interleukin-6, -8, -10 and tumour necrosis factor-α in the faeces of dogs with acute diarrhoea.
Prakash N; Stumbles P; Mansfield CS
N Z Vet J; 2019 May; 67(3):138-142. PubMed ID: 30753790
[TBL] [Abstract][Full Text] [Related]
42. Alpha-1 antitrypsin and electrolytes in some cases of diarrhoea.
el-Hawy AM; Abou-Taleb SA; Massoud AM; Abdel-Khalek YH
J Egypt Soc Parasitol; 1989 Jun; 19(1):131-7. PubMed ID: 2785149
[TBL] [Abstract][Full Text] [Related]
43. Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins.
Cohen A; Boeijinga JK; van Haard PM; Schoemaker RC; van Vliet-Verbeek A
Br J Clin Pharmacol; 1992 Jan; 33(1):33-8. PubMed ID: 1540488
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of Subclinical Enteric Alpha-1-Antitrypsin Loss in Children with Univentricular Circulation Following Total Cavopulmonary Connection.
Breatnach CR; Cleary A; Prendiville T; Crumlish K; Murchan H; McMahon CJ
Pediatr Cardiol; 2018 Jan; 39(1):33-37. PubMed ID: 28879464
[TBL] [Abstract][Full Text] [Related]
45. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Becker K; Niederau C; Frieling T
Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
[TBL] [Abstract][Full Text] [Related]
46. Proteolysis is a confounding factor in the interpretation of faecal calprotectin.
Dumoulin EN; Van Biervliet S; Langlois MR; Delanghe JR
Clin Chem Lab Med; 2015 Jan; 53(1):65-71. PubMed ID: 24995405
[TBL] [Abstract][Full Text] [Related]
47. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
48. Protein losing enteropathy in critically ill adult patients with burns: a preliminary report.
Venkatesh B; Gough J; Ralston DR; Muller M; Pegg S
Intensive Care Med; 2004 Jan; 30(1):162-6. PubMed ID: 14634725
[TBL] [Abstract][Full Text] [Related]
49. Increased faecal alpha-1-antitrypsin excretion in children with persistent diarrhoea associated with enteric pathogens.
Bhan MK; Khoshoo V; Chowdhary D; Jain R; Raj P; Jayashree S; Kumar R
Acta Paediatr Scand; 1989 Mar; 78(2):265-7. PubMed ID: 2784616
[TBL] [Abstract][Full Text] [Related]
50. Gastrointestinal symptoms and permeability in patients with juvenile idiopathic arthritis.
Weber P; Brune T; Ganser G; Zimmer KP
Clin Exp Rheumatol; 2003; 21(5):657-62. PubMed ID: 14611120
[TBL] [Abstract][Full Text] [Related]
51. Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease.
Thorne SA; Hooper J; Kemp M; Somerville J
Eur Heart J; 1998 Mar; 19(3):514-20. PubMed ID: 9568457
[TBL] [Abstract][Full Text] [Related]
52. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin.
Young GP; St John DJ; Cole SR; Bielecki BE; Pizzey C; Sinatra MA; Polglase AL; Cadd B; Morcom J
J Med Screen; 2003; 10(3):123-8. PubMed ID: 14561263
[TBL] [Abstract][Full Text] [Related]
53. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
Hundegger K; Stufler M; Karbach U
Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
[TBL] [Abstract][Full Text] [Related]
54. Gastrointestinal mucosal integrity after prolonged exercise with fluid supplementation.
Peters HP; Wiersma WC; Akkermans LM; Bol E; Kraaijenhagen RJ; Mosterd WL; de Vries WR; Wielders JP
Med Sci Sports Exerc; 2000 Jan; 32(1):134-42. PubMed ID: 10647540
[TBL] [Abstract][Full Text] [Related]
55. Screening for cystic fibrosis by analysis of serum protein in faeces.
Ryley HC; Neale LM; Prosser R; Dodge J
Arch Dis Child; 1976 Aug; 51(8):641-3. PubMed ID: 1085611
[TBL] [Abstract][Full Text] [Related]
56. Assessment of faecal occult blood loss by qualitative and quantitative methods.
Barber MD; Abraham A; Brydon WG; Waldron BM; Williams AJ
J R Coll Surg Edinb; 2002 Apr; 47(2):491-4. PubMed ID: 12018693
[TBL] [Abstract][Full Text] [Related]
57. Characterization and evaluation of immunochemical methods for the measurement of fecal alpha 1-antitrypsin.
Buffone GJ; Shulman RJ
Am J Clin Pathol; 1985 Mar; 83(3):326-30. PubMed ID: 3919562
[TBL] [Abstract][Full Text] [Related]
58. Protein-losing enteropathy associated with Clostridium difficile infection.
Rybolt AH; Bennett RG; Laughon BE; Thomas DR; Greenough WB; Bartlett JG
Lancet; 1989 Jun; 1(8651):1353-5. PubMed ID: 2567373
[TBL] [Abstract][Full Text] [Related]
59. Fecal alpha 1-antitrypsin in breast-fed infants is derived from human milk and is not indicative of enteric protein loss.
Davidson LA; Lönnerdal B
Acta Paediatr Scand; 1990 Feb; 79(2):137-41. PubMed ID: 2321474
[TBL] [Abstract][Full Text] [Related]
60. Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease).
Mizon C; el Yamani J; Colombel JF; Maes P; Balduyck M; Laine A; Cortot A; Tartar A; Mizon J
Clin Sci (Lond); 1991 May; 80(5):517-23. PubMed ID: 1851694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
